Minimally Invasive Biopsy Techniques Market Size & Trends

Liquid Biopsy is the fastest growing segment, North America is the largest regional market

The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical

Key Market Drivers

The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in "Global cancer burden growing, amidst mounting need for services," there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.

Key Market Challenges

The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.

Key Market Trends

Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.

Key Market Players Profiled:

F. Hoffmann-La Roche AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
QIAGEN NV
Guardant Health, Inc.
Veracyte, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
NeoGenomics Laboratories, Inc.
Adaptive Biotechnologies Corporation

Report Scope:

In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories:

By Product Offered:

Tests
Kits & Consumables
Instruments

By Technique:

Liquid Biopsy
Optical Biopsy
Brush Biopsy
Pigmented Lesion Assays
Others

By Circulating Biomarker:

Circulating Tumor Cells (CTCs)
Cell Free DNA (cfDNA)
Circulating Tumor DNA (ctDNA)
Extracellular Vesicles
Others

By Application:

Clinical
Therapeutic

By End User:

Hospitals & Clinics
Ambulatory Care Center
Academic & Research Institutions

By Region:

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Minimally Invasive Biopsy Techniques Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Biopsy Techniques Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
5.2.4. By Application (Clinical, Therapeutic)
5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map

6. North America Minimally Invasive Biopsy Techniques Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Offered
6.2.2. By Technique
6.2.3. By Circulating Biomarker
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Offered
6.3.1.2.2. By Technique
6.3.1.2.3. By Circulating Biomarker
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Offered
6.3.2.2.2. By Technique
6.3.2.2.3. By Circulating Biomarker
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Offered
6.3.3.2.2. By Technique
6.3.3.2.3. By Circulating Biomarker
6.3.3.2.4. By Application
6.3.3.2.5. By End User

7. Europe Minimally Invasive Biopsy Techniques Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Offered
7.2.2. By Technique
7.2.3. By Circulating Biomarker
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Offered
7.3.1.2.2. By Technique
7.3.1.2.3. By Circulating Biomarker
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Offered
7.3.2.2.2. By Technique
7.3.2.2.3. By Circulating Biomarker
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Offered
7.3.3.2.2. By Technique
7.3.3.2.3. By Circulating Biomarker
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Offered
7.3.4.2.2. By Technique
7.3.4.2.3. By Circulating Biomarker
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Offered
7.3.5.2.2. By Technique
7.3.5.2.3. By Circulating Biomarker
7.3.5.2.4. By Application
7.3.5.2.5. By End User

8. Asia-Pacific Minimally Invasive Biopsy Techniques Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Offered
8.2.2. By Technique
8.2.3. By Circulating Biomarker
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Offered
8.3.1.2.2. By Technique
8.3.1.2.3. By Circulating Biomarker
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Offered
8.3.2.2.2. By Technique
8.3.2.2.3. By Circulating Biomarker
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Offered
8.3.3.2.2. By Technique
8.3.3.2.3. By Circulating Biomarker
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Offered
8.3.4.2.2. By Technique
8.3.4.2.3. By Circulating Biomarker
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Offered
8.3.5.2.2. By Technique
8.3.5.2.3. By Circulating Biomarker
8.3.5.2.4. By Application
8.3.5.2.5. By End User

9. Middle East & Africa Minimally Invasive Biopsy Techniques Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Offered
9.2.2. By Technique
9.2.3. By Circulating Biomarker
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Offered
9.3.1.2.2. By Technique
9.3.1.2.3. By Circulating Biomarker
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Offered
9.3.2.2.2. By Technique
9.3.2.2.3. By Circulating Biomarker
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Offered
9.3.3.2.2. By Technique
9.3.3.2.3. By Circulating Biomarker
9.3.3.2.4. By Application
9.3.3.2.5. By End User

10. South America Minimally Invasive Biopsy Techniques Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Offered
10.2.2. By Technique
10.2.3. By Circulating Biomarker
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Offered
10.3.1.2.2. By Technique
10.3.1.2.3. By Circulating Biomarker
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Offered
10.3.2.2.2. By Technique
10.3.2.2.3. By Circulating Biomarker
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Offered
10.3.3.2.2. By Technique
10.3.3.2.3. By Circulating Biomarker
10.3.3.2.4. By Application
10.3.3.2.5. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Minimally Invasive Biopsy Techniques Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. F. Hoffmann-La Roche AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. PerkinElmer Inc.
15.4. QIAGEN NV
15.5. Guardant Health, Inc.
15.6. Veracyte, Inc.
15.7. Myriad Genetics, Inc.
15.8. Biocept, Inc.
15.9. NeoGenomics Laboratories, Inc.
15.10. Adaptive Biotechnologies Corporation

16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Minimally Invasive Biopsy Techniques market report include:

F. Hoffmann-La Roche AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
QIAGEN NV
Guardant Health, Inc.
Veracyte, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
NeoGenomics Laboratories, Inc.
Adaptive Biotechnologies Corporation

Table Information

Report Attribute	Details
No. of Pages	185
Published	November 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 13.75 Billion
Forecasted Market Value ( USD ) by 2030	$ 24.76 Billion
Compound Annual Growth Rate	10.3%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3975EUR$4,500USD£3,483GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4859EUR$5,500USD£4,257GBP

Minimally Invasive Biopsy Techniques Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Key Market Drivers

Key Market Challenges

Key Market Trends

Key Market Players Profiled: